v3.25.4

CONVERTIBLE DEBT | 12 Months Ended
--- | ---
Dec. 31, 2024
Aspire Biopharma Inc [Member] |
CONVERTIBLE DEBT | NOTE 9 - CONVERTIBLE DEBT As of December 31, 2024 and December 31, 2023, the Company had no outstanding convertible debt.

X
- Definition Convertible Debt Disclosure [Text Block] + References No definition available. + Details
Name: | ASBP_ConvertibleDebtDisclosureTextBlock
Namespace Prefix: | ASBP_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=ASBP_AspireBiopharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |